Skip to main content
Equibles
LBRX logo

LBRX · Lb Pharmaceuticals Inc · Held by Funds

Track LBRX — free

Use LBRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LBRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$39.70 -0.45 (-1.12%) At close · Oct 30
Russell 2000 member Rebalance outlook locked
Market Cap
$1.28B
Shares
32.26M
Volume · Oct 30 429.48K Avg daily vol (3M) 367.84K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of LBRX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 9.37% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.27% 733,194
Index ETFs 7.10% 2,289,243
Active ETFs 0.19% 62,672
Active funds 7.84% 2,527,771
Unclassified 0.38% 122,472
All registered funds 17.78% 5,735,352
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding LBRX

134 fund positions
Fund Balance Value % of Fund Open
BlackRock Health Sciences Opportunities Portfolio 567,627 $26,826,052 0.42%
JPMorgan Small Cap Growth Fund 692,905 $22,488,232 0.86%
VANGUARD TOTAL STOCK MARKET INDEX FUND 672,000 $21,809,760 0.00%
iShares Russell 2000 ETF 581,750 $18,880,696 0.02%
PGIM Jennison Health Sciences Fund 231,150 $10,924,149 0.73%
Fidelity Small Cap Index Fund 244,910 $9,815,993 0.03%
Select Biotechnology Portfolio 197,231 $9,321,137 0.15%
VANGUARD EXTENDED MARKET INDEX FUND 278,887 $9,051,278 0.01%
JPMorgan Small Cap Blend Fund 220,241 $7,147,922 0.42%
BlackRock Health Sciences Term Trust 207,987 $6,750,218 0.63%
VANGUARD RUSSELL 2000 INDEX FUND 128,228 $6,060,055 0.03%
Calamos Timpani Small Cap Growth Fund 144,326 $5,784,586 0.75%
Fidelity Extended Market Index Fund 119,707 $5,657,353 0.01%
Schwab U.S. Small-Cap ETF 117,258 $5,541,613 0.02%
iShares Russell 2000 Value ETF 107,475 $3,488,101 0.02%
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF 105,171 $3,413,325 0.80%
Multi-Manager Small Cap Equity Strategies Fund 68,852 $3,253,946 0.28%
iShares Russell 2000 Growth ETF 99,716 $3,236,283 0.02%
iShares Micro-Cap ETF 75,231 $2,441,622 0.16%
Fidelity Total Market Index Fund 46,522 $2,198,630 0.00%
Schwab Small-Cap Index Fund 54,176 $2,171,374 0.03%
iShares U.S. Pharmaceuticals ETF 63,173 $2,050,280 0.18%
Fidelity Series Total Market Index Fund 37,670 $1,780,284 0.00%
ALPS Medical Breakthroughs ETF 35,483 $1,676,927 0.70%
BlackRock Health Sciences Trust 48,308 $1,567,836 0.27%
Master Small Cap Index Series 41,840 $1,357,917 0.02%
Avantis U.S. Small Cap Equity ETF 27,584 $1,303,620 0.04%
Carillon Chartwell Small Cap Fund 38,729 $1,256,950 0.50%
Nuveen Small Cap Blend Index Fund 29,730 $1,191,578 0.03%
iShares Core S&P Total U.S. Stock Market ETF 35,986 $1,167,926 0.00%
Health Sciences Portfolio 33,445 $1,085,457 0.28%
Carillon Chartwell Small Cap Growth Fund 30,045 $975,110 0.50%
Fidelity Nasdaq Composite Index Fund 17,550 $829,413 0.00%
EQ/2000 Managed Volatility Portfolio 24,276 $787,878 0.02%
Nuveen Equity Index Fund 15,490 $620,839 0.00%
Schwab U.S. Broad Market ETF 12,556 $593,397 0.00%
Schwab Total Stock Market Index Fund 14,457 $579,437 0.00%
VANGUARD RUSSELL 2000 GROWTH INDEX FUND 11,668 $551,430 0.03%
Fidelity Small Cap Value Index Fund 16,543 $536,903 0.02%
VANGUARD RUSSELL 2000 VALUE INDEX FUND 11,095 $524,350 0.04%
Fidelity ZERO Total Market Index Fund 13,015 $521,641 0.00%
LVIP State Street Small-Cap Index Fund 16,000 $519,280 0.02%
PACE Small/Medium Co Growth Equity Investments 12,918 $517,753 0.20%
Franklin Alternative Strategies Fund 9,656 $456,343 0.08%
Virtus Biotech Clinical Trials Etf 10,936 $438,315 0.94%
EQ/Small Company Index Portfolio 13,300 $431,652 0.02%
Innovator IBD(R) Breakout Opportunities ETF 20,097 $431,081 3.18%
Global X Russell 2000 ETF 10,682 $428,135 0.03%
Small Cap Index Fund 8,963 $423,591 0.03%
U.S. Small Cap Equity Fund 10,009 $401,161 0.04%
Showing 1–50 of 134 positions
Key facts CIK 1691082 CUSIP 50180M108 13F (30d) 19 filings 19 filers Visit website Investor relations